# An Open Label, Multi Centre Phase IV Study of Adefovir Dipivoxil in Korean Patients With Chronic Hepatitis B (CHB)

> **NCT01205165** · PHASE4 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 104 (actual)

## Conditions studied

- Hepatitis B, Chronic

## Interventions

- **DRUG:** Adefor dipivoxil

## Key facts

- **NCT ID:** NCT01205165
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-12-17
- **Primary completion:** 2006-04-28
- **Final completion:** 2006-04-28
- **Target enrollment:** 104 (ACTUAL)
- **Last updated:** 2018-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01205165

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01205165, "An Open Label, Multi Centre Phase IV Study of Adefovir Dipivoxil in Korean Patients With Chronic Hepatitis B (CHB)". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT01205165. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*